Glaxo’s ViiV has FDA approval of Apretude for HIV prevention There is also the spin off of the consumer healthcare division

“Satisfactory” results from a drilling programme or assay are OK We’d all also rather prefer better than merely satisfactory 

Open Orphan's subsidiary, hVIVO wins £5m human challenge study contract The study will begin in H2 2022 assessing an antiviral drug

Oracle announces acquisition of Cerner Corp for a total of $28B 2020's second-largest software company dives into the healthcare sector Oracle Corporation (NYSE: ORCL), one of the U

GM'S annual gains have been slashed more than 10% in the last week The departure of Cruise CEO & Chevrolet production halt increased selling momentum Based on the long-term outlook, will the dip attract buyers

  Blackberry's business shift is stirring up the cybersecurity market, but that isn't it... Ahead of Q3 earnings, Blackberry stock is down 3% In what seems like an age ago now

  Investors have remained cautious regarding Palantir's Government contracts Partnership with Dewpoint Therapeutics furthers endeavor into commercial space Palantir's big-data framework has the potential to a

Key points: Spruce Biosciences stock was trading 20% lower during premarket hours. It appears investors were taking profits on their positions. The company’s l

Key points: Cen Fite Biopharma announced that one of the patients in its phase II clinical study had a full recovery from liver cancer. The patient had been treated for hepatocellular ca

Rolls Royce Holding PLC (LON: RR) has fallen 3% on news of the Qatari investment into the small nuclear r

Key points: Oriole Resources released positive phase 2 drilling results from its Bibemi project. The company has started the third drilling phase and expects to report Q1 2022.

Society Pass Inc (NASDAQ: SOPA) has jumped 48% premarket. The rise is on news it is to be part of the Russell 2000 Index from market open today.

The three highest dividend payers on the London market are miners and this could be attractive for income seekers However, miners are subject to revenue sq

Key points: Valirx restated the terms of its licensing agreement with CRT for the VAL201 drug molecule. The move will allow Valirx to move forward with its sub-licensing agreement with T

Purplebricks Group PLC (LON: PURP) might well be seen now as being only for speculators This is fine, of course it is, for speculation is as valid an activ

Key points: Capital Minerals shares barely moved despite the company’s positive interim results and operations update. Investors seemed unimpressed by the company’s achievements, includi

Drax Group PLC (LON: DRX) is subj

Helium One is searching for high-grade helium in Tanzania Long-term supply controlled by the US Federals, are becoming exhausted

Key points: Hurricane Energy finally concluded its investigation into the events leading to the rejection of its restructuring plan in June. The company’s non-executive directors exonera

  Rivian's backer Ford might be better positioned for a larger EV market share Tesla is still situated as the market leader but is often prone to periods of volatility. Toyota's ambitious plans could prove fr